Aurobindo Pharma Share price target & analyst calls

₹1,823.2+16.00 (+0.89%)
As of 13 Nov 2026

Avg 1-year target

6 of 9 long-term calls BUY

₹1,713.756.0% below today's price

Aurobindo Pharma's average 1-year share price target is ₹1,713.75, the average of 8 advisors' latest targets. Targets range from ₹950 to ₹2,195.

Latest: Nuvama Wealth ₹2,195 · 6 Nov 2026

10
7 BUY · 3 SELL, all horizons
8
with an active 1Y target
42%
43 of 103 closed calls hit
115
all horizons, open and closed

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips · page 3 of 3

← Back to filtered view
BUYTarget₹1,680
PGbyPrakash GabaStop-loss hit
Intraday* · 10 Aug 2026 · entry ₹1,668 · via CNBC Awaaz.exit ₹1,640
BUYTarget₹1,650
PGbyPrakash GabaStop-loss hit
Intraday* · 6 Aug 2026 · entry ₹1,625 · via CNBC Awaaz.exit ₹1,600
BUYTarget₹1,640
ASbyAmit SethStop-loss hit
Intraday* · 30 Jul 2026 · entry ₹1,601.5 · via CNBC Awaaz.exit ₹1,580
BUYTarget₹1,600
PGbyPrakash GabaStop-loss hit
Intraday* · 22 Jul 2026 · entry ₹1,580 · via CNBC Awaaz.exit ₹1,560
BUYTarget₹1,725
Intraday* · 4 Nov 2026 · entry ₹1,698 · via CNBC Awaaz.exit ₹1,707.2
BUYTarget₹1,690
Intraday · 28 Oct 2026 · entry ₹1,625 · via Zee Business (Live)exit ₹1,646.5
BUYTarget₹1,775
Intraday* · 24 Sept 2026 · entry ₹1,732.4 · via CNBC Awaaz.exit ₹1,714.7
BUYTarget₹1,750
Intraday* · 24 Sept 2026 · entry ₹1,719.7 · via CNBC Awaaz.exit ₹1,714.7
BUYTarget₹1,775
Intraday* · 21 Sept 2026 · entry ₹1,731 · via Zee Business (Live)exit ₹1,712
BUYTarget₹1,700
Intraday · 8 Sept 2026 · entry ₹1,679.3 · via CNBC Awaaz.exit ₹1,678.4
BUYTarget₹1,768
Intraday* · 1 Sept 2026 · entry ₹1,700 · via NDTV Profit (Live)exit ₹1,678.1
BUYTarget₹1,640
Intraday* · 26 Aug 2026 · entry ₹1,624 · via CNBC Awaaz.exit ₹1,619.3
BUYTarget₹1,648
Intraday* · 25 Aug 2026 · entry ₹1,621.6 · via Zee Business (Live)exit ₹1,614.9
BUYTarget₹1,600
Intraday · 30 Jun 2026 · entry ₹1,581.2 · via Zee Business (Live)exit ₹1,575.8
BUYTarget₹1,530
ASbyAmit Seth○ No trade
Intraday · 5 Jun 2026 · entry ₹1,490 · via CNBC Awaaz.

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks

Showing 101–115 of 115